Valacyclovir
NDC 85766-271, Valacyclovir, tablet, from Sportpharm LLC.
- Product NDC
- 85766-271
- Status
- Listed
- Labeler
- Sportpharm LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85766-271 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALACYCLOVIR HYDROCHLORIDE1000 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85766-271-02 | 85766027102 | 2 TABLET in 1 BOTTLE (85766-271-02) |
| 85766-271-04 | 85766027104 | 4 TABLET in 1 BOTTLE (85766-271-04) |
| 85766-271-06 | 85766027106 | 6 TABLET in 1 BOTTLE (85766-271-06) |
| 85766-271-07 | 85766027107 | 7 TABLET in 1 BOTTLE (85766-271-07) |
| 85766-271-10 | 85766027110 | 10 TABLET in 1 BOTTLE (85766-271-10) |
| 85766-271-14 | 85766027114 | 14 TABLET in 1 BOTTLE (85766-271-14) |
| 85766-271-15 | 85766027115 | 15 TABLET in 1 BOTTLE (85766-271-15) |
| 85766-271-20 | 85766027120 | 20 TABLET in 1 BOTTLE (85766-271-20) |
| 85766-271-30 | 85766027130 | 30 TABLET in 1 BOTTLE (85766-271-30) |
| 85766-271-60 | 85766027160 | 60 TABLET in 1 BOTTLE (85766-271-60) |
| 85766-271-90 | 85766027190 | 90 TABLET in 1 BOTTLE (85766-271-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/14e479b1-8afd-4912-8f93-59b60a0868bc
Use it
Look up 85766-271 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85766-271 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85766-271. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.